Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
{{output}}
Multiple myeloma (MM) remains incurable and patients eventually face the relapse/refractory dilemma. B cell maturation antigen (BCMA)-targeted immunotherapeutic approaches have shown great effectiveness in patients with relapsed/refractory MM, mainly including... ...
